Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05430555
Title A Phase 1/2, First-in-Human, Open-Label, Accelerated-Titration, Two-Part Clinical Trial of TK-8001 in Patients With HLA-A*02:01 Genotype and Advanced-Stage/Metastatic MAGE-A1+ Solid Tumors (IMAG1NE)
Acronym IMAG1NE
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors T-knife GmbH
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | GBR | ESP | DEU | BEL

Facility Status City State Zip Country Details
Universite Catholique de Louvain (UCL) - Cliniques Universitaires Saint-Luc - Institut Roi Albert II Brussels 1000 Belgium Details
Universite Libre de Bruxelles (ULB) - Institut Jules Bordet Anderlecht Brussel 1000 Belgium Details
University Hospital Ghent Ghent 9000 Belgium Details
Centre Hospitalier Universitaire (CHU) de Liège Liège 4000 Belgium Details
Technische Universität Dresden (TU Dresden) Dresden Sachsen 01304 Germany Details
Charité - Universitätsmedizin Berlin - Campus Benjamin Franklin Berlin 12203 Germany Details
Universitatsklinikum Frankfurt, Goethe Universitat Frankfurt 60590 Germany Details
Klinikum der Universität München Munich 81377 Germany Details
Universitätsklinikum Würzburg Würzburg 97080 Germany Details
The Netherlands Cancer Institute Amsterdam 1066 Netherlands Details
Hospital Universitario Vall d´Hebrón Barcelona 08035 Spain Details
START Madrid-HM CIOCC Madrid 28050 Spain Details
Clínica Universidad de Navarra Pamplona 31008 Spain Details
The Christie NHS Foundation Trust Manchester M19 2WE United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field